Company Performance Metrics
Kenneth Buechler: President, Chief Scientific Officer and co-founderPast Role: Hybritech Incorporated, Senior Research Scientist
Biosite Incorporated provides diagnostic products and antibody development technologies for sever diseases. It provides seversl products such as Triage drug of abuse panel, a point-of-care diagnostic test for detecting overdosed prescription and illicit drugs; Triage TOX Drug Screen, a fluorescence immunoassay to detect abused drugs; Triage cardiac
panel, a diagnosis aid for heart attack; and Triage BNP test, a diagnosis and assessment aid for the heart failure; and other products.
It also provides Triage D-dimer test, an immunoassay for use as an aid in the assessment and evaluation of patients having disseminated intravascular coagulation or thromboembolic events. Furthermore, it offers medical education, technical service and support, and consulting services.
Biosite Incorporated distributes its products through distributors in the United States and internationally. It was established in 1988 and is based in San Diego, California with sales offices in Switzerland, the Asia Pacific, the Netherlands, France, Germany, Italy, Spain, and the United Kingdom. Currently it operates as a subsidiary of Alere Inc.
